Cullinan Therapeutics, Inc. (CGEM) › EPS (Diluted)Cullinan Therapeutics, Inc. (CGEM) — EPS (Diluted)Annual figures by fiscal year, from SEC filings.2021: $-1.522022: $2.382023: $-3.69$-3.692021EPS (Diluted) (USD/shares)2023Fiscal YearEPS (Diluted)Change YoY2023$-3.69-255.0%2022$2.38+256.6%2021$-1.52—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeTotal AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share